Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
US6911543B2 · kind B2 · utility
42Cited by
36References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2002 |
| Grant date | Jun 28, 2005 |
| Priority date | — |
| Expiry date | Oct 4, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula I: wherein Azabicyclo is These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which α7 is known to be involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.